-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2024.
- Tarsus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$23.4M, a 40.2% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$134M, a 24.9% decline year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$136M, a 119% decline from 2022.
- Tarsus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$62.1M, a 349% decline from 2021.
- Tarsus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.8M, a 48.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)